Yu X - Search Results

1

Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer.

Wang W, Huang Z, Yu Z, Zhuang W, Zheng W, Cai Z, Shi L, Yu X, Lou G, Hong W, Zhang Y, Chen M, Song Z. Wang W, et al. Among authors: yu x, yu z. Front Oncol. 2020 Oct 9;10:572853. doi: 10.3389/fonc.2020.572853. eCollection 2020. Front Oncol. 2020. PMID: 33163403 Free PMC article.

2

Solitary extramedullary plasmacytoma in retroperitoneum: a case report and review of the literature.

Hong W, Yu XM, Jiang MQ, Chen B, Wang XB, Yang LT, Zhang YP. Hong W, et al. World J Gastroenterol. 2009 May 21;15(19):2425-7. doi: 10.3748/wjg.15.2425. World J Gastroenterol. 2009. PMID: 19452592 Free PMC article. Review.

3

Palatine tonsillar metastasis of lung cancer during chemotherapy.

Hong W, Wang X, Yu XM, Chen B, Ding GJ, Zhang YP. Hong W, et al. Among authors: yu xm. Int J Clin Exp Pathol. 2012;5(5):468-71. Epub 2012 May 23. Int J Clin Exp Pathol. 2012. PMID: 22808302 Free PMC article.

4

Adenovirus-mediated interferon-γ gene therapy induced human pancreatic carcinoma Capan-2 cell apoptosis in vitro and in vivo.

Xie FJ, Zhao P, Zhang YP, Liu FY, Nie XL, Zhu YH, Yu XM, Zheng QQ, Mao WM, Lu HY, Wei H, Huang W. Xie FJ, et al. Anat Rec (Hoboken). 2013 Apr;296(4):604-10. doi: 10.1002/ar.22661. Epub 2013 Feb 9. Anat Rec (Hoboken). 2013. PMID: 23401468 Free article.

5

Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression to gemcitabine-based chemotherapy for advanced non-small cell lung cancer in a Chinese Han population.

Hong W, Wang K, Zhang YP, Kou JY, Hong D, Su D, Mao WM, Yu XM, Xie FJ, Wang XJ. Hong W, et al. J Zhejiang Univ Sci B. 2013 Mar;14(3):207-15. doi: 10.1631/jzus.B1200101. J Zhejiang Univ Sci B. 2013. PMID: 23463763 Free PMC article.

6

[Efficacy of icotinib for advanced non-small cell lung cancer patients with EGFR status identified].

Song Z, Yu X, Cai J, Shao L, Lin B, He C, Zhang B, Zhang Y. Song Z, et al. Among authors: yu x. Zhongguo Fei Ai Za Zhi. 2013 Mar;16(3):138-43. doi: 10.3779/j.issn.1009-3419.2013.03.04. Zhongguo Fei Ai Za Zhi. 2013. PMID: 23514942 Free PMC article. Chinese.

7

[Efficacy and safety of pemetrexed or gemcitabine combined with carboplatin as the first-line therapy in elderly patients with advanced non-small cell lung cancer].

Shi X, Yu XM, Zhang YP, Zhao J. Shi X, et al. Among authors: yu xm. Zhonghua Zhong Liu Za Zhi. 2013 Mar;35(3):221-4. doi: 10.3760/cma.j.issn.0253-3766.2013.03.013. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 23880005 Clinical Trial. Chinese.

8

Re-administration after the failure of gefitinib or erlotinib in patients with advanced non-small cell lung cancer.

Song Z, Yu X, He C, Zhang B, Zhang Y. Song Z, et al. Among authors: yu x. J Thorac Dis. 2013 Aug;5(4):400-5. doi: 10.3978/j.issn.2072-1439.2013.07.28. J Thorac Dis. 2013. PMID: 23991294 Free PMC article.

9

Helicobacter pylori infection and esophageal cancer risk: an updated meta-analysis.

Xie FJ, Zhang YP, Zheng QQ, Jin HC, Wang FL, Chen M, Shao L, Zou DH, Yu XM, Mao WM. Xie FJ, et al. World J Gastroenterol. 2013 Sep 28;19(36):6098-107. doi: 10.3748/wjg.v19.i36.6098. World J Gastroenterol. 2013. PMID: 24106412 Free PMC article. Review.

10

Efficacy and safety of icotinib in Chinese patients with advanced non-small cell lung cancer after failure of chemotherapy.

Shao L, Zhang B, He C, Lin B, Song Z, Lou G, Yu X, Zhang Y. Shao L, et al. Among authors: yu x. Chin Med J (Engl). 2014;127(2):266-71. Chin Med J (Engl). 2014. PMID: 24438614

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34,250 results

Search Page

Filters